| Literature DB >> 23645641 |
David Shprecher1, Colgan T Sloan, Benson Sederholm.
Abstract
Cyclobenzaprine is commonly used as a muscle relaxant and analgesic. Given its tricyclic properties, serotonin syndrome is a potential side effect of this drug. We report an unusual case of a patient who experienced symptoms of delirium and hyperkinetic movement disorders shortly after initiating treatment with cyclobenzaprine and oxycodone. Symptoms resolved within 48 h of discontinuing cyclobenzaprine. This case serves to remind clinicians to monitor for serotonin syndrome when initiating cyclobenzaprine, and when adding opiate or antidepressant medications to the regimen.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23645641 PMCID: PMC3669814 DOI: 10.1136/bcr-2013-008997
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X